责任方 Leigh R. Hochberg, MD, PhD 在 ClinicalTrials.gov 登记 BrainGate2 皮质内神经接口系统用于失语人群的可行性研究（BG-Aphasia-01，NCT07791459）。研究目的为获得初步器械安全性信息，并以尝试说话的方式验证失语者在计算机屏幕上生成文字及可听见的计算机生成语音的原理可行性。本次为登记摘要，未提供招募状态、分期或结果数据。
原文摘录：Aldurazyme RSS Authorised This medicine is authorised for use in the European Union laronidase Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview This is a summary of the European public assessment re … This page was last updated on 06/11/2026
原文摘录：Lacosamide Accord RSS Authorised This medicine is authorised for use in the European Union lacosamide Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview This is a summary of the European public assess … 56 KB - DOCX) First published: 28/05/2025 View This page was last updated on 06/11/2026
原文摘录：The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic
原文摘录：See all DONs related to this event Situation at a glance On 20 October 2026, the National IHR Focal Point (NFP) of France notified WHO regarding the first documented human infection with Shamonda virus (SHAV). … item/2026-DON623
关注理由：这篇神经内科资料可用于了解领域进展，研究设计、结果和局限性值得一起阅读。